低氘氫水實驗室 研究項目

  1. 極超高純氫氣研究—7N、8N維米製程氫氣
  2. 固態儲氫器研究、太空船用固態儲氫器研究
  3. 低氘飽和氫水製程研究及應用研究
  4. 低氘水用於生物實驗及製藥應用研究
  5. 氫氣呼吸之劑量及物理效應研究
  6. 低氘水用於育苗育種農業生技研究
  7. 氫氣用於食品科學研究
  8. 低氘水用於食品科學研究
  9. 呼吸氫氣及低氘飽和氫水之於癌症、中風、巴金森症、妥瑞症、糖尿病、心肌損傷、肝損傷、腦中風、放射治療損傷、老年癡呆、心肌硬塞、痛風、COPD、異位性皮膚炎、僵直性脊椎炎、過敏、紅斑性狼瘡及自體免疫性疾病之觀察研究

電郵: ddh2water@gmail.com

LINE ID: @ddh2 點此加好友



新型含氫氣透析液(當心假氫水破財又傷身)

分享這篇文章:

 

新型含氫氣透析液

已有2350次閱讀 2010-5-20 17:59 個人分類氫氣醫學臨床 | 系統分類觀點評述 | 關鍵詞:氫氣,透析

加氫氣的新型血液透析的臨床研究

長期血液透析引起的慢性炎症是預後不良的重要原因。但是,治療長期血液透析引起的慢性炎症的手段非常有限。許多動物實驗結果發現,氫氣具有器官氧化和炎症損傷的良好保護作用。我們用含氫氣電解液開發出新型血液透析系統,並進行了臨床效應觀察。用電解方法製備氫氣並將氫氣溶解到反滲水中並和透析液混合,氫氣濃度可達到48 ppb 。受試對象為病情穩定使用常規透析液治療的21 名患者,換用新含氫氣透析液月,每週三次治療。結果發現,在治療過程中,沒有任何明顯的不良反應,比較突出的效果是,透析後血壓正常比例明顯增加,治療前只有21% 收縮壓低於140 mmHg ,而新透析後達到62% ,有顯著統計學區別。雖然透析相關指標沒有明顯變化(透析效果無區別?),但血液中代表炎症反應的MCP1 MPO 顯著下降。該研究表明,加氫氣新型透析液對血壓控制效果良好,並能有效控制炎症反應。該新型透析液給尿毒症患者帶了福音。要知道,這種新型透析液成本並不增加多少。

 

Nephrol Dial Transplant. 2010 Apr 12. [Epub ahead of print]

A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial.

Nakayama M , Nakano H , Hamada H , Itami N , Nakazawa R , Ito S .

1 Tohoku University Hospital, Department of Blood Purification (Sendai).

Abstract

 

Background. Chronic inflammation in haemodialysis (HD) patients indicates a poor prognosis. However, therapeutic approaches are limited. Hydrogen gas (H(2)) ameliorates oxidative and inflammatory injuries to organs in animal models. We developed an HD system using a dialysis solution with high levels of dissolved H(2) and examined the clinical effects. Methods. Dialysis solution with H(2) (average of 48 ppb) was produced by mixing dialysate concentrates and reverse osmosis water containing dissolved H(2) generated by a water electrolysis technique. Subjects comprised 21 stable patients on standard HD who were switched to the test HD for 6 months at three sessions a week. Results. During the study period, no adverse clinical signs or symptoms were observed. A significant decrease in systolic blood pressure (SBP) before and after dialysis was observed during the study, and a significant number of patients achieved SBP <140 mmHg after HD (baseline, 21%; 6 months, 62%; P < 0.05). Changes in dialysis parameters were minimal, while significant decreases in levels of plasma monocyte chemoattractant protein 1 (P < 0.01) and myeloperoxidase (P < 0.05) were identified. Conclusions. Adding H(2) to haemodialysis solutions ameliorated inflammatory reactions and improved BP control. This system could offer a novel therapeutic option for control of uraemia.

PMID: 20388631 [PubMed – as supplied by publisher]

 

 


 

台灣氫水實驗室 TEL:0963-210-763

email: ddh2water@gmail.com

台灣氫水實驗室部落格:http://blog.xuite.net/hworker77086600/twblog

歡迎來電索取氫水辨認方法(防止喝到傷身的假氫水) 

氫水,氫分子、氫氣、健康氫水,水素水,負電位,ORP,抗氧化,抗自由基,氫分子醫學,氫水,Hydrogen water,氫氣、氫,台灣氫水研究中心,氫思語,孫學軍,太田成男,鹼性離子水,小分子水,能量水,電解水,富氫水,負氫水,活水,健康,養生,活力,大氫鬆,小氫鬆,氫水機,水素,水素水機,王群光,氫氧機,綠加利,活美水素水,低氘水,活性原子氫,富氫水,負氫水,每日水素,活氫水,氫氧造水機,百樂,負氫,氫博士,氫水棒,氫源,新德美,HOH,鹼性活氫水,氫美機,負氫離子水,氫氣棒,呼吸氫氣,氫氧療法,加氫水,氫水、健康氫水、水素水、負電位、ORP、抗氧化、抗自由基 、氫分子醫學、氫水、Hydrogen water、氫氣、氫、氫水、台灣氫水實驗室、台灣氫水研究中心、氫思語、孫學軍、太田成男、鹼性離子水、小分子水、能量水、電解水、富氫水、負氫水、活水、健康、養生、活力、大氫鬆、小氫鬆、氫水機、水素、水素水機、王群光、氫氧機、綠加利、活美水素水、低氘水、活性原子氫、富氫水、負氫水、每日水素、活氫水、氫氧造水機、百樂、負氫、氫博士、氫水棒、氫源、新德美、HOH、鹼性活氫水、氫美機、負氫離子

全文 

本文引用地址:http://blog.sciencenet.cn/blog-41174-326752.html 
上一篇:金屬元素也屬於自由基
下一篇:氫氣治療腎臟缺血再灌注損傷

 

低氘氫水實驗室

低氘氫水實驗室

TEL:0963-788-693
email: ddh2water@gmail.com
Line ID:h2water(加Line優先回覆)
台灣氫水實驗室部落格: http://blog.xuite.net/hworker77086600/twblog
FB氫友團:https://www.facebook.com/groups/301217133566722
FB粉絲專頁:https://www.facebook.com/h2ulife/
歡迎Email或加Line索取氫水辨認方法(防止喝到傷身的假氫水)提供玻璃瓶裝飽和氫水供對比,免費兩瓶給你測試,收運費120元。(運費是宅配業者收去的)

  • Facebook


    error: Content is protected !!